Abstract
Antiinflammatory effects of indomethacin farnesil (IMF), a novel prodrug of indomethacin, was examined after both oral and local administration. In the air pouch carrageenin-induced inflammation, an oral dose of IMF exerted dose dependent inhibitory effects on the accumulation of inflammatory exudate fluid and the migration of leukocytes into the exudate. Both the increased vascular permeability and the prostaglandin E2 levels in the exudate fluid were reduced by IMF. Significant levels of free indomethacin were detected in the pouch fluid. In spite of the inability of IMF to inhibit prostaglandin synthesis in a cell free cyclooxygenase system, IMF injected locally inhibited carrageenin paw edema, and the inhibitory effect was comparable to that of indomethacin itself. When injected locally into the paw together with carrageenin,14C-IMF was effectively converted to its active metabolite, indomethacin. The indomethacin concentration in the paw tissue was comparable to that of indomethacin injected paws with the same molar dose of free indomethacin.
Similar content being viewed by others
References
W. M. O'Brien,Indomethacin: survey of clinical trials Clin. Pharmacol. Exp. Ther.9, 94–107 (1968).
R. H. Gifford,Chemotherapy of rheumatoid arthritis. Ration. Drug. Ther.7, 1–7 (1973).
H.-D. Dell, M. Doersing, W. Fisher, H. Jacobi and R. Kamp,Biochemical studies on acemetacin. Arzneim.-Forsch.30, 1371–1383 (1980).
T. Y. Shen,Towards more selective NSAID. Eur. J. Rheumatol. Inflammation1, 167–172 (1978).
I. Tanaka, H. Yoshizumi, Y. Tanaka, S. Takeda, C. Kamei, N. Nakaya, K. Kitazumi, H. Tagami and K. Tasaka,Pharmacological profiles of 2-carboxyphenyl-1-(4chlorobenzoyl)-5-methoxy-2-methyl-indol-3-acetate and 2-[(2-Carboxyphenoxy)-carbonyl]phenyl-l-(4chlorobenzoyl)-5-methoxy-2-methylindol-3-acetate, a new antiinflammatory agent. Arzneim.-Forsch/Drug Res.36, 703–709 (1986).
I. D. Salsedo, L. F. Arias and B. P. Greenberg,Fenbufen, a new nonsteroidal antiinflammatory agent: comparison with phenylbutazone in rheunatoid arthritis. Current Ther. Res.18, 295–302 (1975).
Y. Mizushima,Basic and clinical studies of prodrugs of nonsteroidal anti-inflammatory drugs. Pharmacology25, 39–45 (1982).
S. Kobayashi, R. Hashida, H. Shirota, K. Yoshimatsu, K. Harada, S. Abe, I. Yamatsu, Y. Mizushima and Y. Nagai,Effect of E-0710, a farnesyl ester of indomethacin, on rat synovial cell prostaglandin production in culture, Drug Exptl. Clin. Res.10, 845–851 (1984).
S. Kobayashi, H. Shirota, Y. Katoh, R. Hashida, J. Nagaoka, S. Abe and I. Yamatsu,Anti-inflammatory activity of a new nonsteroidal anti-inflammatory prodrugs, indometacin farnesil, in experimental animals. Pharmacometrics36, 91–98 (1988).
H. Selye,Use of glanuloma pouch technic in the study of anti-phylogistic corticoid. Proc. Soc. exp. Biol. Med.82, 328–333 (1953).
M. Fukuhara and S. Tsurufuji,The effect of locally injected anti-inflammatory drugs on the carrageenin granuloma in rats. Biochem. Pharmacol.18, 475–484 (1969).
K. Ohuchi, S. Yoshino, K. Kakaoka, S. Tsurufuji and L. Levine,A possible role of arachidonate metabolism in allergic air pouch inflammation in rats. Int. Archs. Allergy appl. Immun.68, 326–331 (1982).
C. G. Van Arman, A. J. Begany, L. M. Miller and H. H. Pless,Some details of the inflammation caused by yeast and carrageenin. J. Pharmacol. Exp. Ther.150, 328–334 (1965).
M. Murakami, K. Oketani, H. Fujisaki, T. Wakabayashi, N. Sano, R. Watanabe and Y. Katoh,Indometacin farnesil, a new anti-inflammatory prodrug: effect on gastrointestinal mucosa in rat. Pharmacometrics (in press).
M. Mishima, C. Yamato, S. Kobayashi and K. Kinoshita,Metabolic fate of E-0710, an anti-inflammatory prodrug, in experimental animals. Folia Pharmacol. Japan.82, 175 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kumakura, S., Mishima, M., Kobayashi, S. et al. Inhibitory effect of indomethacin farnesil, a novel antiinflammatory prodrug, on carrgeenin-induced inflammation in rats. Agents and Actions 29, 286–291 (1990). https://doi.org/10.1007/BF01966459
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01966459